<p>阿卡迪亚医疗保健公司（NASDAQ:ACHC - 获取免费报告）在周三的交易中股价下跌了 6.5%，因加拿大皇家银行将该股票的目标价从 19.00 美元下调至 17.00 美元。加拿大皇家银行目前对该股票的评级为跑赢大盘。阿卡迪亚医疗保健的股价最低曾达到 11.63 美元，最后交易价为 11.7310 美元。在午盘交易中，约有 2,557,743 股易手，较日均交易量 2,763,329 股下降了 7%。该股票此前收盘价为 12.55 美元。</p>
<p>获取 <strong>阿卡迪亚医疗保健</strong> 的提醒：</p>
<ul>
<li>Neurogene 股票暴跌 44%：这家生物科技公司还有希望吗？</li>
</ul>
<p>其他一些券商也对 ACHC 发布了报告。德意志银行将阿卡迪亚医疗保健的目标价从 33.00 美元下调至 20.00 美元，并在 12 月 3 日的研究报告中给予该股票 “买入” 评级。瑞穗证券在 12 月 18 日的报告中将阿卡迪亚医疗保健的目标价从 22.00 美元下调至 17.00 美元，并给予 “中性” 评级。美国银行在 12 月 3 日的研究报告中将阿卡迪亚医疗保健的评级从 “中性” 下调至 “表现不佳”，并将该公司的目标价从 21.50 美元下调至 13.00 美元。Weiss Ratings 在 10 月 8 日的研究报告中重新发布了对阿卡迪亚医疗保健的 “卖出（d）” 评级。最后，Cantor Fitzgerald 在 12 月 3 日的报告中设定了阿卡迪亚医疗保健的目标价为 17.00 美元。七位投资分析师对该股票给予了 “买入” 评级，六位给予了 “持有” 评级，两位给予了 “卖出” 评级。根据 MarketBeat 的数据，阿卡迪亚医疗保健目前的平均评级为 “持有”，平均目标价为 18.64 美元。</p>
<p><strong>查看我们对阿卡迪亚医疗保健的最新分析</strong></p>
<h2>对阿卡迪亚医疗保健的对冲基金看法</h2>
<p>几家大型投资者最近修改了对 ACHC 的持股。Allworth Financial LP 在第二季度将其在阿卡迪亚医疗保健的持股增加了 676.4%。Allworth Financial LP 现在拥有该公司 1,351 股股票，价值 31,000 美元，在此期间又购买了 1,177 股。EverSource Wealth Advisors LLC 在第二季度将其在阿卡迪亚医疗保健的持股增加了 54.8%。EverSource Wealth Advisors LLC 现在拥有该公司 1,404 股股票，价值 32,000 美元，在此期间又收购了 497 股。Hantz Financial Services Inc. 在第三季度将其在阿卡迪亚医疗保健的持股增加了 501.9%。Hantz Financial Services Inc. 现在拥有该公司 2,185 股股票，价值 54,000 美元，在上个季度又购买了 1,822 股。CWM LLC 在第二季度将其在阿卡迪亚医疗保健的持股增加了 105.1%。CWM LLC 现在拥有该公司 2,633 股股票，价值 60,000 美元，在此期间又购买了 1,349 股。最后，Quent Capital LLC 在第三季度以 71,000 美元的价值收购了阿卡迪亚医疗保健的新头寸。</p>
<h2>阿卡迪亚医疗保健股票下跌 6.6%</h2>
<p>该公司的流动比率为 1.44，速动比率为 1.44，债务与股本比率为 0.73。该股票的市值为 10.8 亿美元，市盈率为 10.02，PEG 比率为 3.47，贝塔值为 0.88。该公司有 50 日简单移动平均线为 15.27 美元，200 日简单移动平均线为 20.17 美元。</p>
<p>阿卡迪亚医疗保健（NASDAQ:ACHC - 获取免费报告）最近在 11 月 5 日发布了季度财报。该公司报告每股收益为 0.72 美元，超出市场共识预期的 0.71 美元 0.01 美元。阿卡迪亚医疗保健的净利润率为 3.29%，股本回报率为 7.66%。该公司在本季度的收入为 8.5157 亿美元，而分析师预期为 8.5243 亿美元。在去年同期，该公司每股收益为 0.91 美元。该公司的收入同比增长了 4.4%。阿卡迪亚医疗保健已将其 2025 财年的指导目标设定为 2.350-2.450 每股收益。股票研究分析师预计阿卡迪亚医疗保健公司将在当前财年发布每股收益 3.38 美元。</p>
<h2>阿卡迪亚医疗保健公司简介</h2>
<p>（获取免费报告）</p>
<p>阿卡迪亚医疗保健公司，NASDAQ: ACHC，是一家总部位于田纳西州富兰克林的公开交易的行为健康服务提供商。该公司成立于 2005 年，通过有机扩张和战略收购不断发展，已成为美国心理健康和成瘾治疗领域的领先专家。</p>
<p>阿卡迪亚经营着一个多元化的住院精神病医院、住院治疗中心、门诊诊所和强化门诊项目的网络。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票超过阿卡迪亚医疗保健</li>
<li>Zacks 将 BSEM 的目标价设定为 25.50 美元！</li>
<li>将这些代码输入您的普通经纪账户</li>
<li>请勿删除，立即阅读</li>
<li>超过 200 万盎司已定义 - 仍然处于故事的早期阶段</li>
<li>华尔街股票挑选者命名 2026 年第一只股票</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在阿卡迪亚医疗保健吗？</h2>
<p>在考虑阿卡迪亚医疗保健之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而阿卡迪亚医疗保健并不在名单上。</p>
<p>虽然阿卡迪亚医疗保健目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

阿卡迪亚医疗保健

<p>阿卡迪亚医疗保健（NASDAQ:ACHC）股价下跌 6.5%，因加拿大皇家银行将其目标价从 19.00 美元下调至 17.00 美元。该股最低交易价为 11.63 美元，最后交易价为 11.7310 美元。其他券商也下调了目标价，德意志银行将其设定为 20.00 美元，瑞穗则为 17.00 美元。尽管评级下调，七位分析师仍将该股评为买入，六位评为持有，二位评为卖出。阿卡迪亚报告上个季度每股收益为 0.72 美元，略高于预期，营收为 8.5157 亿美元，同比增长 4.4%</p>

<p>Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) shares were down 6.5% during trading on Wednesday after Royal Bank Of Canada lowered their price target on the stock from $19.00 to $17.00. Royal Bank Of Canada currently has an outperform rating on the stock. Acadia Healthcare traded as low as $11.63 and last traded at $11.7310. Approximately 2,557,743 shares changed hands during mid-day trading, a decline of 7% from the average daily volume of 2,763,329 shares. The stock had previously closed at $12.55.</p>
<div class="lb-trans"><p>阿卡迪亚医疗保健公司（NASDAQ:ACHC - 获取免费报告）在周三的交易中股价下跌了 6.5%，因加拿大皇家银行将该股票的目标价从 19.00 美元下调至 17.00 美元。加拿大皇家银行目前对该股票的评级为跑赢大盘。阿卡迪亚医疗保健的股价最低曾达到 11.63 美元，最后交易价为 11.7310 美元。在午盘交易中，约有 2,557,743 股易手，较日均交易量 2,763,329 股下降了 7%。该股票此前收盘价为 12.55 美元。</p>
</div><p>Get <strong>Acadia Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>阿卡迪亚医疗保健</strong> 的提醒：</p>
</div><ul>
<li>Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?&#34;</li>
</ul>
<div class="lb-trans"><ul>
<li>Neurogene 股票暴跌 44%：这家生物科技公司还有希望吗？</li>
</ul>
</div><p>A number of other brokerages have also issued reports on ACHC. Deutsche Bank Aktiengesellschaft dropped their target price on Acadia Healthcare from $33.00 to $20.00 and set a &#34;buy&#34; rating on the stock in a research report on Wednesday, December 3rd. Mizuho lowered their price objective on shares of Acadia Healthcare from $22.00 to $17.00 and set a &#34;neutral&#34; rating on the stock in a report on Thursday, December 18th. Bank of America downgraded shares of Acadia Healthcare from a &#34;neutral&#34; rating to an &#34;underperform&#34; rating and decreased their target price for the company from $21.50 to $13.00 in a research report on Wednesday, December 3rd. Weiss Ratings reissued a &#34;sell (d)&#34; rating on shares of Acadia Healthcare in a research report on Wednesday, October 8th. Finally, Cantor Fitzgerald set a $17.00 price objective on Acadia Healthcare in a report on Wednesday, December 3rd. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, Acadia Healthcare currently has an average rating of &#34;Hold&#34; and an average price target of $18.64.</p>
<div class="lb-trans"><p>其他一些券商也对 ACHC 发布了报告。德意志银行将阿卡迪亚医疗保健的目标价从 33.00 美元下调至 20.00 美元，并在 12 月 3 日的研究报告中给予该股票 “买入” 评级。瑞穗证券在 12 月 18 日的报告中将阿卡迪亚医疗保健的目标价从 22.00 美元下调至 17.00 美元，并给予 “中性” 评级。美国银行在 12 月 3 日的研究报告中将阿卡迪亚医疗保健的评级从 “中性” 下调至 “表现不佳”，并将该公司的目标价从 21.50 美元下调至 13.00 美元。Weiss Ratings 在 10 月 8 日的研究报告中重新发布了对阿卡迪亚医疗保健的 “卖出（d）” 评级。最后，Cantor Fitzgerald 在 12 月 3 日的报告中设定了阿卡迪亚医疗保健的目标价为 17.00 美元。七位投资分析师对该股票给予了 “买入” 评级，六位给予了 “持有” 评级，两位给予了 “卖出” 评级。根据 MarketBeat 的数据，阿卡迪亚医疗保健目前的平均评级为 “持有”，平均目标价为 18.64 美元。</p>
</div><p><strong>View Our Latest Analysis on Acadia Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我们对阿卡迪亚医疗保健的最新分析</strong></p>
</div><h2>Hedge Funds Weigh In On Acadia Healthcare</h2>
<div class="lb-trans"><h2>对阿卡迪亚医疗保健的对冲基金看法</h2>
</div><p>Several large investors have recently modified their holdings of ACHC. Allworth Financial LP boosted its holdings in shares of Acadia Healthcare by 676.4% during the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company's stock worth $31,000 after buying an additional 1,177 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock worth $32,000 after acquiring an additional 497 shares during the period. Hantz Financial Services Inc. lifted its holdings in Acadia Healthcare by 501.9% during the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company's stock worth $54,000 after purchasing an additional 1,822 shares during the last quarter. CWM LLC boosted its stake in Acadia Healthcare by 105.1% in the 2nd quarter. CWM LLC now owns 2,633 shares of the company's stock valued at $60,000 after purchasing an additional 1,349 shares during the period. Finally, Quent Capital LLC acquired a new position in Acadia Healthcare in the 3rd quarter valued at $71,000.</p>
<div class="lb-trans"><p>几家大型投资者最近修改了对 ACHC 的持股。Allworth Financial LP 在第二季度将其在阿卡迪亚医疗保健的持股增加了 676.4%。Allworth Financial LP 现在拥有该公司 1,351 股股票，价值 31,000 美元，在此期间又购买了 1,177 股。EverSource Wealth Advisors LLC 在第二季度将其在阿卡迪亚医疗保健的持股增加了 54.8%。EverSource Wealth Advisors LLC 现在拥有该公司 1,404 股股票，价值 32,000 美元，在此期间又收购了 497 股。Hantz Financial Services Inc. 在第三季度将其在阿卡迪亚医疗保健的持股增加了 501.9%。Hantz Financial Services Inc. 现在拥有该公司 2,185 股股票，价值 54,000 美元，在上个季度又购买了 1,822 股。CWM LLC 在第二季度将其在阿卡迪亚医疗保健的持股增加了 105.1%。CWM LLC 现在拥有该公司 2,633 股股票，价值 60,000 美元，在此期间又购买了 1,349 股。最后，Quent Capital LLC 在第三季度以 71,000 美元的价值收购了阿卡迪亚医疗保健的新头寸。</p>
</div><h2>Acadia Healthcare Stock Down 6.6%</h2>
<div class="lb-trans"><h2>阿卡迪亚医疗保健股票下跌 6.6%</h2>
</div><p>The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.73. The stock has a market cap of $1.08 billion, a P/E ratio of 10.02, a PEG ratio of 3.47 and a beta of 0.88. The firm has a 50-day simple moving average of $15.27 and a two-hundred day simple moving average of $20.17.</p>
<div class="lb-trans"><p>该公司的流动比率为 1.44，速动比率为 1.44，债务与股本比率为 0.73。该股票的市值为 10.8 亿美元，市盈率为 10.02，PEG 比率为 3.47，贝塔值为 0.88。该公司有 50 日简单移动平均线为 15.27 美元，200 日简单移动平均线为 20.17 美元。</p>
</div><p>Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. The business had revenue of $851.57 million during the quarter, compared to analysts' expectations of $852.43 million. During the same quarter in the previous year, the company earned $0.91 EPS. The business's revenue was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>阿卡迪亚医疗保健（NASDAQ:ACHC - 获取免费报告）最近在 11 月 5 日发布了季度财报。该公司报告每股收益为 0.72 美元，超出市场共识预期的 0.71 美元 0.01 美元。阿卡迪亚医疗保健的净利润率为 3.29%，股本回报率为 7.66%。该公司在本季度的收入为 8.5157 亿美元，而分析师预期为 8.5243 亿美元。在去年同期，该公司每股收益为 0.91 美元。该公司的收入同比增长了 4.4%。阿卡迪亚医疗保健已将其 2025 财年的指导目标设定为 2.350-2.450 每股收益。股票研究分析师预计阿卡迪亚医疗保健公司将在当前财年发布每股收益 3.38 美元。</p>
</div><h2>Acadia Healthcare Company Profile</h2>
<div class="lb-trans"><h2>阿卡迪亚医疗保健公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.</p>
<div class="lb-trans"><p>阿卡迪亚医疗保健公司，NASDAQ: ACHC，是一家总部位于田纳西州富兰克林的公开交易的行为健康服务提供商。该公司成立于 2005 年，通过有机扩张和战略收购不断发展，已成为美国心理健康和成瘾治疗领域的领先专家。</p>
</div><p>Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.</p>
<div class="lb-trans"><p>阿卡迪亚经营着一个多元化的住院精神病医院、住院治疗中心、门诊诊所和强化门诊项目的网络。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Acadia Healthcare</li>
<li>Zacks Puts $25.50 target on BSEM!</li>
<li>Punch these codes into your ordinary brokerage account</li>
<li>Do not delete, read immediately</li>
<li>More than 2 million ounces defined - and still early in their story</li>
<li>Wall Street Stock picker Names #1 Stock of 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过阿卡迪亚医疗保健</li>
<li>Zacks 将 BSEM 的目标价设定为 25.50 美元！</li>
<li>将这些代码输入您的普通经纪账户</li>
<li>请勿删除，立即阅读</li>
<li>超过 200 万盎司已定义 - 仍然处于故事的早期阶段</li>
<li>华尔街股票挑选者命名 2026 年第一只股票</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Acadia Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在阿卡迪亚医疗保健吗？</h2>
</div><p>Before you consider Acadia Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑阿卡迪亚医疗保健之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而阿卡迪亚医疗保健并不在名单上。</p>
</div><p>While Acadia Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然阿卡迪亚医疗保健目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

阿卡迪亚医疗保健（NASDAQ:ACHC）在分析师下调评级后股价下跌了 6.5%